Neurotransmitter transporters play a key role in depression and neurodegenerative diseases (NDD) such as Alzheimer's and Parkinson's. The ability to monitor serotonin, norepinephrine, and dopamine transporter (SERT, NET and DAT, respectively) activity in expressing cells, transfected or primary, is key to a better understanding of these diseases.